Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) was a big mover last session, as its shares rose almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday’s rally reverses the recent downtrend for the company, as the stock is now down over 24% in the past one-month time frame.
Over the last 30 days, the company witnessed four positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Dicerna Pharmaceuticals currently has a Zacks Rank #2 (Buy).
Another favorably ranked biomedical stock is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) with a Zacks Rank #1 (Strong Buy).
Is DRNA going up? Or down? Predict to see what others think: Up or Down
DICERNA PHARMA (DRNA): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
Original post